MedImmune Speeding Up Drug Applications

Gaithersburg biotechnology company MedImmune, which was acquired by drugmaker AstraZeneca earlier this year, said it expects to have at least three new drug candidates in trials by 2010 and hopes to have an average of six new drug applications for submission per year.
baltimoresun.com